177Lu-EDTMP

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug Name177Lu-EDTMP

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsBone metastasesProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIranIndia

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesUniversità Di Pisa

China Registration ClassN/A

Develop Information

Active CompaniesGilan University Of Medical Sciences

Inactive CompaniesN/A

Active IndicationsBone metastasesProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A